Rapid Uptitration of Guideline-Directed Medical Therapy for Heart Failure

This publication has 10 references indexed in Scilit:

• Streamlined Heart Failure Optimization Protocol for Patients With Reduced Left Ventricular Ejection Fraction
  JACC: Heart Failure, 2025
• Eligibility and GDMT up-titration success in heart failure: A real-world assessment
  PLOS ONE, 2025
• Eligibility for rapid up-titration of guideline-directed medical therapy of real-world patients hospitalised for heart failure
  Cardiology, 2024
• How to Tackle Therapeutic Inertia in Heart Failure with Reduced Ejection Fraction. A Scientific Statement of the Heart Failure Association of the ESC
  European Journal of Heart Failure, 2024
• Similarities and Differences Between Pragmatic Trials and Hybrid Effectiveness-Implementation Trials
  Journal of General Internal Medicine, 2024
• It Takes an Average of 17 Years for Evidence to Change Practice—the Burgeoning Field of Implementation Science Seeks to Speed Things Up
  JAMA, 2023
• Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial
  The Lancet, 2022
• An Electronically Delivered Patient-Activation Tool for Intensification of Medications for Chronic Heart Failure With Reduced Ejection Fraction
  Circulation, 2020
• Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials
  The Lancet, 2020
• Medical Therapy for Heart Failure With Reduced Ejection Fraction
  JACC, 2018